The global smart pill boxes and bottles market was valued at US$ 144.2 million in 2022 and is expected to reach US$ 160.2 million in 2023. With the increasing usage of smart pill boxes and bottles to enhance medication adherence in patients, the market is expected to register a CAGR of 9.3% between 2023 and 2033, reaching US$ 388.2 million by the end of 2033.
| Attributes | Details |
|---|---|
| Market CAGR (From 2023 to 2033) | 9.3% |
| Market Size (2022) | US$ 144.2 million |
| Market Size (2023) | US$ 160.2 million |
| Market Size (2033) | US$ 388.2 million |
| Global Market Absolute Dollar Growth (US$ million/billion) | US$ 228.0 million |
Medication adherence has always been a significant challenge for the healthcare industry. Poor adherence to appropriate medication therapy often leads to complications, death, and increased healthcare costs. In order to improve this medication adherence, patients adopt smart medication adherence technologies like smart pill boxes and bottles. This has brought the global smart pill boxes and bottle market into the spotlight.
A small pill box or pill container is a multi-compartment compliance aid for storing scheduled doses of medications. The adoption of smart pill boxes and bottles helps patients consume medicines on time without any errors, making it easier to dispense medication. Therefore, smart pill boxes and bottles play a key role in improving medication compliance and adherence in patients.
The rising incidence of chronic disease along with the rapidly increasing geriatric population and growing need for improving medication adherence is a key factor boosting smart pill boxes and bottle sales. According to the Centers for Disease Control and Prevention’s (CDC’s) report published in September 2016, one in four Medicare participants aged 65 or older (i.e., 5 million people), do not take their blood pressure medicine as directed. As a result, medical professionals recommend smart pill boxes and bottles for older patients with chronic diseases.
Innovation has been a key tool for manufacturers to increase their smart pill boxes and bottle sales. Leading smart pill box & bottle manufacturers have developed advanced smart medication products with web-based applications and mobile applications to help patients take their medications correctly. For instance, in 2021, AdhereTech, a leading provider and pioneer of smart devices that connect patients to care via real-time interventions, unveiled the Aidia System to advance medication adherence technologies.
Regionally, North America remains at the epicenter of smart pill boxes and bottles market growth, accounting for a significant market share in 2023. Growth in the North American market is driven by the availability of advanced Research and Development facilities, increased prevalence of several chronic diseases, presence of leading market players, and growing need for tablets with simple dispensing systems and easy-to-open systems for the elderly population.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The key developments in the market are based upon the introduction of smart sensors and cellular technology into the plastic walls of the bottle to accurately measure single units of solid or liquid medication.
The market observed a decline in the BPS values owed to the additional cost incurred for the device, over the actual cost of medication. The adverse effects observed among the patients switching from sporadic to smart pill boxes & bottles resulted in poor patient adoption of these devices.
Patients who need regular supervision for medication routines can benefit from these devices, and hence the market is anticipated to be expected to observe positive growth over the forecast years.
As per FMI, the global demand for smart pill boxes & bottles is set to grow at a CAGR of 9.3% between 2023 and 2033. Growth in the smart pill boxes & bottles market is driven by the rising prevalence of chronic diseases worldwide, the increasing need for improving patient medication compliance and adherence, the growing popularity of personalized medicine/treatment, technological advancements in smart pill boxes and bottles, the growing popularity of home healthcare services, surge in geriatric population worldwide.
Smart pillboxes and smart pill bottles have made the process of filling and distributing medications much easier. These smart medication adherence technologies help patients and caregivers track medication compliance by sending alerts and are especially gaining traction in home healthcare.
Smart products are like automatic pill dispensers that organize pills that need to be taken as per a schedule. They significantly increase efficiency in drug dispensation count and thus eliminate the life-threatening errors made by humans.
The rising prevalence of chronic diseases coupled with an increasing need for improving patient compliance and adherence with medication is a significant factor boosting the growth of the smart pill boxes and bottle market.
In order to improve medication adherence, people usually opt for smart technologies like smart pill boxes and bottles. This may continue to expand the global market size during the forecast period.
Short-term Growth: Growing geriatric population worldwide along with the rising popularity of home healthcare is expected to improve the smart pill boxes and bottle market growth.
Mid-term Growth: Advancements in smart pill boxes and bottles that are focusing on developing smart pill boxes and bottles with advanced features like remote monitoring may influence the sales of smart pill boxes & bottles.
Long-term Growth: The rapid expansion of the medication adherence packaging market, growing demand for medical healthcare devices, growth in the automatic pill dispenser market across developing regions, and advancement in telehealth software are poised to further expand the smart pill boxes & bottles market size.
Principal Consultant
The use of smart pill boxes and bottles has considerably increased medication adherence in patients, though, there are numerous challenges restricting the market expansion. Some of these factors include the high cost of smart pill boxes and bottles, as well as a lack of understanding of smart pill dispensers in emerging markets.
Smart Pill Boxes Sales Expected to Outpace Smart Pill Boxes Through 2033
| Attributes | Details |
|---|---|
| Product Type | Smart Pill Boxes |
| CAGR % 2017 to 2022 | 10.6% |
| CAGR % 2023 to 2033 | 9.1% |
Based on product type, the smart pill boxes & bottles market is segmented into smart pill boxes and smart pill bottles. Among these, the smart pill boxes segment accounts for a substantial share of 75.3% of the global market during the forecast period. However, according to FMI, smart pill bottles are expected to lead the segment growth, owing to the rising adoption of smart pill bottles due to improved adherence and patient satisfaction, and their ability to effectively track patient behaviour.
During the projection period, the rapid expansion of the prescription bottle market is anticipated to boost the growth of this category.
| Attributes | Details |
|---|---|
| Top Indication | Dementia |
| CAGR % 2017 to 2022 | 11.2% |
| CAGR % 2023 to 2033 | 9.3% |
In light of the expanding senior therapy pool, which is more prone to dementia, the dementia sector is predicted to hold a significant market share. Previously, the dementia market recorded a CAGR of 11.2% from 2017 to 2022. Whereas, the market's dementia category is expected to register a CAGR of 9.3% from 2023 to 2033.
According to the WHO, over 50 million individuals worldwide have dementia, with nearly 60% living in low- and middle-income countries. Every year, about 10 million new cases are reported. At any given time, the estimated proportion of the general population aged 60 and up with dementia is between 5-8%.
Demand for Smart Pill Boxes & Bottles to Remain High in Long-Term Care Centres
In terms of end users, the market is segmented into seniors care & assisted living, long-term care centres, and home care settings. As per the latest smart pill boxes & bottles market trends, the long-term care centres segment is likely to dominate the global market during the forecast period.
This can be attributed to the rising prevalence of disabilities, the increasing geriatric population who cannot care for themselves, and the increase in long-term care facilities worldwide.
Long-term care facilities provide a wide range of services, including medical and personal care, to persons who are unable to live independently. Healthcare professionals in these centres employ smart technologies like smart pill boxes and bottles to improve medication adherence and monitor patient behaviour.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Country | United States of America |
|---|---|
| HCAGR (From 2017 to 2022) | 10.5% |
| CAGR (From 2023 to 2033) | 7.4% |
| Country | United Kingdom |
|---|---|
| HCAGR (From 2017 to 2022) | 8.7% |
| CAGR (From 2023 to 2033) | 10.2% |
| Country | China |
|---|---|
| HCAGR (From 2017 to 2022) | 13.4% |
| CAGR (From 2023 to 2033) | 11.3% |
| Country | Japan |
|---|---|
| HCAGR (From 2017 to 2022) | 12.6% |
| CAGR (From 2023 to 2033) | 8.0% |
| Country | South Korea |
|---|---|
| HCAGR (From 2017 to 2022) | 12.8% |
| CAGR (From 2023 to 2033) | 9.9% |
Rise in Alzheimer's Diseases and Availability of Advanced Bluetooth-based Pill Boxes Driving Growth in the USA Market
| Attributes | Details |
|---|---|
| United States Market Size (US$ million/billion) by End of Forecast Period (2033) | US$ 111.7 million |
| United States Market Absolute Dollar Growth (US$ million/billion) | US$ 56.9 million |
Over the years, the USA has become one of the most lucrative markets for smart pill boxes and bottles and this trend is likely to continue during the forecast period. Growth in the USA market is driven by the increasing adoption of advanced technologies, the surge in chronic diseases like diabetes, cancer, and dementia, the strong presence of leading smart pill boxes and bottle manufacturers, and the rapid expansion of the automatic pill dispenser market.
The rising incidence of Alzheimer's disease is the key factor pushing sales of smart pill boxes and bottles in the USA. According to the USA Department of Health and Human Services, Administration for Community Living (ACL), Alzheimer’s disease is the most common dementia among older adults, affecting about 5.8 million United States residents aged 65 and older in 2020. Furthermore, this is expected to reach around 14 million by 2050. Therefore, creating a conducive environment for the smart pill boxes and bottle market growth in the country.
Similarly, the growing popularity of smart pill technologies and the availability of advanced products like Bluetooth smart pill boxes and bottles are going to further expand the market size in the country during the forthcoming years.
The surging Use of Automatic Pill Dispensers is Propelling the Market Expansion in the United Kingdom
| Attributes | Details |
|---|---|
| United Kingdom Market Size (US$ million/billion) by End of Forecast Period (2033) | US$ 22.0 million |
| United Kingdom Market Absolute Dollar Growth (US$ million/billion) | US$ 13.7 million |
The smart pill boxes and bottles market in the United Kingdom is expected to grow rapidly due to rising government backing, the presence of advantageous reimbursement policies, rising Research and Development expenditure, and the growing popularity of home healthcare.
Rising rates of different chronic and acute diseases in the United Kingdom have highlighted the need to improve patient adherence to treatment. As a result, modern technological goods such as automatic pill dispensers are used to keep track of drugs and reduce difficulties.
Increasing automatic pill dispenser manufacturers in the country, as well as rising healthcare spending, may boost the United Kingdom's smart pill boxes & bottles market share in the coming years.
| Attributes | Details |
|---|---|
| China Market Size (US$ million/billion) by End of Forecast Period (2033) | US$ 25.8 million |
| China Market Absolute Dollar Growth (US$ million/billion) | US$ 17.0 million |
Asia Pacific is experiencing a rising trend due to the geriatric population that is more susceptible to chronic diseases. Increasing awareness, favorable government policies, increased healthcare expenditure, and modernization of medical infrastructure, primarily in emerging nations such as India, China, and Japan are expected to drive market growth. The prevalence of psoriasis and increased awareness about it has an impact on market growth.
| Attributes | Details |
|---|---|
| Japan Market Size (US$ million/billion) by End of Forecast Period (2033) | US$ 18.8 million |
| Japan Market Absolute Dollar Growth (US$ million/billion) | US$ 10.1 million |
Due to the increasing number of elderly people and growing consumer awareness of technologically advanced items, the Asia Pacific region is predicted to have considerable growth throughout the projection period. It is anticipated that growing smart device adoption in homecare settings would support the expansion of the Asia Pacific market.
| Attributes | Details |
|---|---|
| South Korea Market Size (US$ million/billion) by End of Forecast Period (2033) | US$ 9.3 million |
| South Korea Market Absolute Dollar Growth (US$ million/billion) | US$ 5.7 million |
Big Sky Labs has raised US$ 1 million in seed funding to create a gadget that can dispense pharmaceuticals as well as deliver other home health services including wellness checks and health monitoring.
The PillPez device, a medication dispenser, delivers pills at predetermined periods throughout the day from pre-loaded pharmaceutical strips accessible at most pharmacies. If a person fails to take the medications, PillPez sends an escalating series of reminders, including to caretakers or family members.
Adhere Tech, Medipense Inc., Koninklijke Philips N.V., Pillsy, Inc., MedMinder, PharmRight Corporation & Livi, MedReady Inc., e-pill, LLC, DoseSmart Inc, SMRxT INC, Pillo, INC, and Prill Drill, Inc. are a few of the top makers of smart pill boxes & bottles.
Recent Development:
| Date | In 2019 |
|---|---|
| Company | Pilloxa |
| Details | In order to address the rising issue of patient compliance, Pilloxa, a digital healthcare company, and Bayer AB embarked on a strategic partnership for an innovative smart pillbox. |
| Date | November 2020 |
|---|---|
| Company | Pill Connect |
| Details | Jonathan Milner, Catapult Ventures, and Shallcross Partners funded GBP 510,000 in Pill Connect, formerly known as Elucid mHealth, for the commercial launch of its electronic smart pill container in the USA and Europe. |
| Date | January 2020 |
|---|---|
| Company | Medipense |
| Details | Medipense, a digital devices manufacturer, live demonstrated about medication management and remote monitoring solution named RxPense, at Arab Health 2020. |
The smart pill boxes & bottles market was valued at US$ 144.2 million in 2022.
By 2033, the smart pill boxes & bottles market is anticipated to reach US$ 388.2 M million.
The smart pill boxes & bottles market is expected to yield US$ 160.2 million by 2023.
From 2017 to 2022, the smart pill boxes & bottles market a CAGR of 10.7%.
From 2023 to 2033, the smart pill boxes & bottles market is expected to register a CAGR of 9.3%.
Smart pill boxes segment in product type category to expand at a CAGR of 9.1% during the forecast period.
From 2023 to 2033, the Dementia segment is likely to accelerate at a CAGR of 9.3%.
1. Executive Summary | Smart Pill Boxes & Bottles Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyers
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ million) & Volume (Units) Analysis, 2017 to 2022
4.2. Current and Future Market Size Value (US$ million) & Volume (Units) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By Product Type, 2017 to 2022
5.3. Current and Future Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By Product Type, 2023 to 2033
5.3.1. Smart Pill Boxes
5.3.2. Smart Pill Bottles
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017 to 2022
5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033
6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Indication
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By Indication, 2017 to 2022
6.3. Current and Future Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By Indication, 2023 to 2033
6.3.1. Dementia
6.3.2. Parkinson’s Disease
6.3.3. Cancer Management
6.3.4. Diabetes Care
6.3.5. Geriatric Care
6.3.6. Disability
6.3.7. Others
6.4. Y-o-Y Growth Trend Analysis By Indication, 2017 to 2022
6.5. Absolute $ Opportunity Analysis By Indication, 2023 to 2033
7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By End User, 2017 to 2022
7.3. Current and Future Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033
7.3.1. Seniors Care & Assisted Living
7.3.2. Long-term Care Centers
7.3.3. Home Care Settings
7.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2022
7.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By Region, 2017 to 2022
8.3. Current Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. East Asia
8.3.5. South Asia
8.3.6. Oceania
8.3.7. Middle East and Africa (MEA)
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
9.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. United States of America
9.2.1.2. Canada
9.2.2. By Product Type
9.2.3. By Indication
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By Indication
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
10.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Argentina
10.2.1.4. Rest of Latin America
10.2.2. By Product Type
10.2.3. By Indication
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By Indication
10.3.4. By End User
10.4. Key Takeaways
11. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
11.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. Italy
11.2.1.3. France
11.2.1.4. United Kingdom
11.2.1.5. Spain
11.2.1.6. Benelux
11.2.1.7. Nordic
11.2.1.8. Rest of Europe
11.2.2. By Product Type
11.2.3. By Indication
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By Indication
11.3.4. By End User
11.4. Key Takeaways
12. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
12.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.2. By Product Type
12.2.3. By Indication
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By Indication
12.3.4. By End User
12.4. Key Takeaways
13. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
13.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Thailand
13.2.1.3. Indonesia
13.2.1.4. Malaysia
13.2.1.5. Rest of South Asia
13.2.2. By Product Type
13.2.3. By Indication
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type
13.3.3. By Indication
13.3.4. By End User
13.4. Key Takeaways
14. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
14.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. Australia
14.2.1.2. New Zealand
14.2.2. By Product Type
14.2.3. By Indication
14.2.4. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product Type
14.3.3. By Indication
14.3.4. By End User
14.4. Key Takeaways
15. MEA Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
15.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. Northern Africa
15.2.1.3. South Africa
15.2.1.4. Rest of MEA
15.2.2. By Product Type
15.2.3. By Indication
15.2.4. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product Type
15.3.3. By Indication
15.3.4. By End User
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. United States of America
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Product Type
16.1.2.2. By Indication
16.1.2.3. By End User
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Product Type
16.2.2.2. By Indication
16.2.2.3. By End User
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Product Type
16.3.2.2. By Indication
16.3.2.3. By End User
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Product Type
16.4.2.2. By Indication
16.4.2.3. By End User
16.5. Argentina
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Product Type
16.5.2.2. By Indication
16.5.2.3. By End User
16.6. Germany
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Product Type
16.6.2.2. By Indication
16.6.2.3. By End User
16.7. Italy
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Product Type
16.7.2.2. By Indication
16.7.2.3. By End User
16.8. France
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Product Type
16.8.2.2. By Indication
16.8.2.3. By End User
16.9. United Kingdom
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Product Type
16.9.2.2. By Indication
16.9.2.3. By End User
16.10. Spain
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Product Type
16.10.2.2. By Indication
16.10.2.3. By End User
16.11. Benelux
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Product Type
16.11.2.2. By Indication
16.11.2.3. By End User
16.12. Nordic
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Product Type
16.12.2.2. By Indication
16.12.2.3. By End User
16.13. China
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Product Type
16.13.2.2. By Indication
16.13.2.3. By End User
16.14. Japan
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Product Type
16.14.2.2. By Indication
16.14.2.3. By End User
16.15. South Korea
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2022
16.15.2.1. By Product Type
16.15.2.2. By Indication
16.15.2.3. By End User
16.16. India
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2022
16.16.2.1. By Product Type
16.16.2.2. By Indication
16.16.2.3. By End User
16.17. Thailand
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2022
16.17.2.1. By Product Type
16.17.2.2. By Indication
16.17.2.3. By End User
16.18. Indonesia
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2022
16.18.2.1. By Product Type
16.18.2.2. By Indication
16.18.2.3. By End User
16.19. Malaysia
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2022
16.19.2.1. By Product Type
16.19.2.2. By Indication
16.19.2.3. By End User
16.20. Australia
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2022
16.20.2.1. By Product Type
16.20.2.2. By Indication
16.20.2.3. By End User
16.21. New Zealand
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2022
16.21.2.1. By Product Type
16.21.2.2. By Indication
16.21.2.3. By End User
16.22. GCC Countries
16.22.1. Pricing Analysis
16.22.2. Market Share Analysis, 2022
16.22.2.1. By Product Type
16.22.2.2. By Indication
16.22.2.3. By End User
16.23. Northern Africa
16.23.1. Pricing Analysis
16.23.2. Market Share Analysis, 2022
16.23.2.1. By Product Type
16.23.2.2. By Indication
16.23.2.3. By End User
16.24. South Africa
16.24.1. Pricing Analysis
16.24.2. Market Share Analysis, 2022
16.24.2.1. By Product Type
16.24.2.2. By Indication
16.24.2.3. By End User
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Product Type
17.3.3. By Indication
17.3.4. By End User
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Adhere Tech
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.1.5.2. Product Strategy
18.1.1.5.3. Channel Strategy
18.1.2. Medipense Inc.
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.2.5.2. Product Strategy
18.1.2.5.3. Channel Strategy
18.1.3. Koninklijke Philips N.V.
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.3.5.2. Product Strategy
18.1.3.5.3. Channel Strategy
18.1.4. Pillsy, Inc.
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.4.5.2. Product Strategy
18.1.4.5.3. Channel Strategy
18.1.5. MedMinder
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.5.5.2. Product Strategy
18.1.5.5.3. Channel Strategy
18.1.6. PharmRight Corporation & Livi
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.6.5.2. Product Strategy
18.1.6.5.3. Channel Strategy
18.1.7. MedReady Inc.
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.7.5.2. Product Strategy
18.1.7.5.3. Channel Strategy
18.1.8. e-pill, LLC
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.8.5.2. Product Strategy
18.1.8.5.3. Channel Strategy
18.1.9. DoseSmart Inc
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.9.5.2. Product Strategy
18.1.9.5.3. Channel Strategy
18.1.10. SMRxT Inc
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
18.1.10.5.2. Product Strategy
18.1.10.5.3. Channel Strategy
18.1.11. Pillo, Inc
18.1.11.1. Overview
18.1.11.2. Product Portfolio
18.1.11.3. Profitability by Market Segments
18.1.11.4. Sales Footprint
18.1.11.5. Strategy Overview
18.1.11.5.1. Marketing Strategy
18.1.11.5.2. Product Strategy
18.1.11.5.3. Channel Strategy
18.1.12. Prill Drill, Inc.
18.1.12.1. Overview
18.1.12.2. Product Portfolio
18.1.12.3. Profitability by Market Segments
18.1.12.4. Sales Footprint
18.1.12.5. Strategy Overview
18.1.12.5.1. Marketing Strategy
18.1.12.5.2. Product Strategy
18.1.12.5.3. Channel Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Explore Healthcare Insights
View Reports
Smart Pill Boxes & Bottles Market
